Over the years, several mechanisms by which TAMs can modulate tumor microenvironment have been described, including immunosuppressive actions through programmed death-ligand 1 (PD-L1) expression and the promotion of tumor growth, invasion, and angiogenesis [86,87,88]. The gene discussed is CD274; the disease is neoplasm.